Role of genetic analyses in cardiology - Part I: Mendelian diseases: Cardiac channelopathies

Research output: Contribution to journalArticle

78 Citations (Scopus)

Abstract

Genetic analysis can be performed to identify the molecular substrate of inherited arrhythmogenic diseases; however, the role of this information in helping the management of patients is still debated. Here, we support the view that the practical value of genetic analysis is different in the various inherited conditions and that it is strongly influenced by the amount of information available in each disease about genotype-phenotype correlations. In some diseases, clinical management of patients is profoundly affected by the type of the underlying genetic defect; therefore, in these conditions, there is a high priority to introduce genetic analysis into clinical practice. In the absence of genotype-phenotype correlations, genetic testing still can be very useful when there is a clinical advantage in establishing presymptomatic diagnosis or when screening of family members may point to reproductive counseling. Finally, there is a high priority for introducing genetic testing for those genetic diseases in which a limited number of genes allow a high yield of successfully genotyped patients. We have developed a "score" to compare the value of genetic testing in arrhythmogenic diseases and to convey our view that the clinical role of genetic analysis is different in the various inherited cardiomyopathies and channelopathies. Healthcare authorities should become responsive to the advancement of knowledge in this field and should help facilitate access to genotyping for families affected by those conditions in which genetic analysis provides useful information for clinical management.

Original languageEnglish
Pages (from-to)1130-1135
Number of pages6
JournalCirculation
Volume113
Issue number8
DOIs
Publication statusPublished - Feb 2006

Fingerprint

Channelopathies
Genetic Testing
Cardiology
Heart Diseases
Genetic Association Studies
Information Management
Inborn Genetic Diseases
Disease Management
Cardiomyopathies
Counseling
Delivery of Health Care
Genes

Keywords

  • Cardiomyopathy
  • Death, sudden
  • Genetics
  • Hypertrophy
  • Ion channels
  • Myocardium

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Role of genetic analyses in cardiology - Part I : Mendelian diseases: Cardiac channelopathies. / Priori, Silvia G.; Napolitano, Carlo.

In: Circulation, Vol. 113, No. 8, 02.2006, p. 1130-1135.

Research output: Contribution to journalArticle

@article{360c78866a854133b3c9e6c31363d040,
title = "Role of genetic analyses in cardiology - Part I: Mendelian diseases: Cardiac channelopathies",
abstract = "Genetic analysis can be performed to identify the molecular substrate of inherited arrhythmogenic diseases; however, the role of this information in helping the management of patients is still debated. Here, we support the view that the practical value of genetic analysis is different in the various inherited conditions and that it is strongly influenced by the amount of information available in each disease about genotype-phenotype correlations. In some diseases, clinical management of patients is profoundly affected by the type of the underlying genetic defect; therefore, in these conditions, there is a high priority to introduce genetic analysis into clinical practice. In the absence of genotype-phenotype correlations, genetic testing still can be very useful when there is a clinical advantage in establishing presymptomatic diagnosis or when screening of family members may point to reproductive counseling. Finally, there is a high priority for introducing genetic testing for those genetic diseases in which a limited number of genes allow a high yield of successfully genotyped patients. We have developed a {"}score{"} to compare the value of genetic testing in arrhythmogenic diseases and to convey our view that the clinical role of genetic analysis is different in the various inherited cardiomyopathies and channelopathies. Healthcare authorities should become responsive to the advancement of knowledge in this field and should help facilitate access to genotyping for families affected by those conditions in which genetic analysis provides useful information for clinical management.",
keywords = "Cardiomyopathy, Death, sudden, Genetics, Hypertrophy, Ion channels, Myocardium",
author = "Priori, {Silvia G.} and Carlo Napolitano",
year = "2006",
month = "2",
doi = "10.1161/CIRCULATIONAHA.105.563205",
language = "English",
volume = "113",
pages = "1130--1135",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Role of genetic analyses in cardiology - Part I

T2 - Mendelian diseases: Cardiac channelopathies

AU - Priori, Silvia G.

AU - Napolitano, Carlo

PY - 2006/2

Y1 - 2006/2

N2 - Genetic analysis can be performed to identify the molecular substrate of inherited arrhythmogenic diseases; however, the role of this information in helping the management of patients is still debated. Here, we support the view that the practical value of genetic analysis is different in the various inherited conditions and that it is strongly influenced by the amount of information available in each disease about genotype-phenotype correlations. In some diseases, clinical management of patients is profoundly affected by the type of the underlying genetic defect; therefore, in these conditions, there is a high priority to introduce genetic analysis into clinical practice. In the absence of genotype-phenotype correlations, genetic testing still can be very useful when there is a clinical advantage in establishing presymptomatic diagnosis or when screening of family members may point to reproductive counseling. Finally, there is a high priority for introducing genetic testing for those genetic diseases in which a limited number of genes allow a high yield of successfully genotyped patients. We have developed a "score" to compare the value of genetic testing in arrhythmogenic diseases and to convey our view that the clinical role of genetic analysis is different in the various inherited cardiomyopathies and channelopathies. Healthcare authorities should become responsive to the advancement of knowledge in this field and should help facilitate access to genotyping for families affected by those conditions in which genetic analysis provides useful information for clinical management.

AB - Genetic analysis can be performed to identify the molecular substrate of inherited arrhythmogenic diseases; however, the role of this information in helping the management of patients is still debated. Here, we support the view that the practical value of genetic analysis is different in the various inherited conditions and that it is strongly influenced by the amount of information available in each disease about genotype-phenotype correlations. In some diseases, clinical management of patients is profoundly affected by the type of the underlying genetic defect; therefore, in these conditions, there is a high priority to introduce genetic analysis into clinical practice. In the absence of genotype-phenotype correlations, genetic testing still can be very useful when there is a clinical advantage in establishing presymptomatic diagnosis or when screening of family members may point to reproductive counseling. Finally, there is a high priority for introducing genetic testing for those genetic diseases in which a limited number of genes allow a high yield of successfully genotyped patients. We have developed a "score" to compare the value of genetic testing in arrhythmogenic diseases and to convey our view that the clinical role of genetic analysis is different in the various inherited cardiomyopathies and channelopathies. Healthcare authorities should become responsive to the advancement of knowledge in this field and should help facilitate access to genotyping for families affected by those conditions in which genetic analysis provides useful information for clinical management.

KW - Cardiomyopathy

KW - Death, sudden

KW - Genetics

KW - Hypertrophy

KW - Ion channels

KW - Myocardium

UR - http://www.scopus.com/inward/record.url?scp=33645302141&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645302141&partnerID=8YFLogxK

U2 - 10.1161/CIRCULATIONAHA.105.563205

DO - 10.1161/CIRCULATIONAHA.105.563205

M3 - Article

C2 - 16505190

AN - SCOPUS:33645302141

VL - 113

SP - 1130

EP - 1135

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 8

ER -